Patients can also explore other provider-guided options on the ARSYNL Rx therapies page
[DOI] [PubMed] [Google Scholar] 213.Kandratavicius L., Balista P.A., Wolf D.C., Abrao J., Evora P.R., Rodrigues A.J., Chaves C., Maia-de-Oliveira J.P., Leite J.P., Dursun S.M., et al
Compounded medications are not reviewed or approved by the FDA as finished drug products and are prescribed only when clinically appropriate
Chemical Stability: While BWFI itself is relatively stable, its quality impacts the stability of sensitive research compounds reconstituted with it
Health status considerations: Generally healthy adults with physician clearance, individuals without contraindications (pregnancy, active malignancy, severe organ disease), those willing to commit to proper administration protocols and monitoring, and patients who understand the research-purposes-only status and informed consent requirements